Biotechnology Stocks I Performance Guide: Alnylam Pharmaceuticals, Inc. (ALNY)
ALNY has no dividends.
Table and Chart of ALNY Performance
See what a $1,000 investment in ALNY is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ALNY Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $59.29 |
| End Date | May-10-2024 |
| End Price | $150.47 |
| # Prices | 121 |
| Min Date | Oct-31-2016 |
| Min Price | $35.60 |
| Max Date | Dec-30-2022 |
| Max Price | $237.65 |
| Total Return | 153.79% |
| Annualized Return | 9.68% |
| Current Value of $1,000 Purchase | $2,538 |
| Number Returns | 7,260 |
| Average Return | 62.73% |
| Number Profitable Returns | 5,723 |
| Percent Profitable Returns | 78.83% |
| Number Unprofitable Returns | 1,537 |
| Percent Unprofitable Returns | 21.17% |
| Profitable to Unprofitable Returns Ratio | 3.72 |
| ALNY Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $19,033,252,000 |
| Beta | 0.406 | Price to Sales | 10.27 |
| Earnings per Share | $-2.6300 |
| PE Ratio | None |
| PE to Growth Ratio | -0.49 |
| Price to Book | 142.92 |
| PRICE DATA | |
| 52 Week High | $218.88 |
| 52 Week Low | $141.97 |
| Analyst Target Price | $222.68 |
| 50-Day Moving Average | $149.38 |
| 200-Day Moving Average | $170.28 |
| FINANCIAL DATA | |
| Revenue per Share | $15.97 |
| Revenue | $2,003,335,000 |
| Profit Margin | -16.6% |
| Return on Equity | -1501% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ALNY Compare Returns with S&P 500
ALNY Trendline Chart
ALNY Moving Average Chart
ALNY Stock Return Map - See Patterns of Gains and Losses
ALNY Stock Returns/Purchase Dates